Skip to main content
. 2019 Dec 15;200(12):1487–1495. doi: 10.1164/rccm.201903-0557OC

Figure 1.

Figure 1.

Derivation of the study cohort. Among 15,802 patients in SMART (Isotonic Solutions and Major Adverse Renal Events Trial), 1,641 were admitted to the medical ICU with a diagnosis of sepsis and were included in the primary analysis for the current study.